Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

PTMs of the lytic polysaccharide monooxygenase of Pseudomonas aeruginosa

ABSTRACT: Lytic polysaccharide monooxygenases (LPMOs) are a recently discovered enzyme family that cleave polysaccharides by oxidation. Despite proposed roles in bacterial virulence, no direct functional data exist to validate these claims. Here we show PTMs detected on CpbD.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Pseudomonas Aeruginosa

SUBMITTER: Magnus Arntzen

LAB HEAD: Gustav Vaaje-Kolstad

PROVIDER: PXD018769 | Pride | 2021-01-12

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Similar Datasets

The lytic polysaccharide monooxygenase of Pseudomonas aeruginosa promotes bacterial survival during systemic infection

Project description:Lytic polysaccharide monooxygenases (LPMOs) are a recently discovered enzyme family that cleave polysaccharides by oxidation. Despite proposed roles in bacterial virulence, no direct functional data exist to validate these claims. Here we show that CpbD, the LPMO of the opportunistic pathogen Pseudomonas aeruginosa (PA) is a virulence factor that promotes survival of the bacterium in whole human blood. CbpD was also shown to cleave the glycosidic bonds of the model substrate by an oxidative reaction, a feature that promoted by azurin and pyocyanin. Two redox-active virulence factors co-secreted with the LPMO. Combination of homology modelling, molecular dynamics simulations and small angle X-ray scattering demonstrated that CbpD is a monomeric tri-modular enzyme with highly flexible domain linkers, where domain positioning may be influenced by post translational modifications. Deletion of cbpD rendered P. aeruginosa unable to establish a lethal systemic infection and enhanced bacterial clearance in vivo. Improved bacterial survival of the wildtype was not attributable to dampening of pro-inflammatory responses by the protein, either ex vivo or in vivo. Further quantification of complement products in whole human blood revealed that CbpD reduced the performance of the terminal complement cascade. Importantly, CbpD inactivation by active site mutations abolished both enzyme activity in vitro and function ex vivo, indicating that ligand oxidation is crucial for CbpD virulence function. Finally, profiling of the bacterial and splenic proteome showed that the lack of this single enzyme resulted in substantial re-organization of the bacterial defense systems in vitro and the targeting of distinct host proteins/pathways in vivo.

2021-01-28 | PXD021888 | Pride

The lytic polysaccharide monooxygenase of Pseudomonas aeruginosa promotes bacterial survival during systemic infection

2021-01-28 | PXD017971 | Pride

Immunization with lytic polysaccharide monooxygenase CbpD induces protective immunity against Pseudomonas aeruginosa pneumonia

Project description:Bacterial lytic polysaccharide monooxygenases (LPMOs) are understudied in the context of infection disease. We demonstrated that Pseudomonas aeruginosa LPMO CbpD is a virulence determinant in pneumonia. Moreover, Mice immunized with CbpD generate robust antibody responses that provide protection against lethal lung infection

2023-07-26 | PXD039298 | Pride

A seven-transmembrane methyltransferase catalysing N-terminal histidine methylation of lytic polysaccharide monooxygenases

Project description:Lytic polysaccharide monooxygenases (LPMOs) are oxidative enzymes that help break down lignocellulose, making them highly attractive for improving biomass utilization in biotechnological purposes. The catalytically essential N-terminal histidine (His1) of LPMOs is post-translationally modified by methylation in filamentous fungi to protect them from auto-oxidative inactivation, however, the responsible methyltransferase enzyme is unknown. Using mass-spectrometry-based quantitative proteomics in combination with systematic CRISPR/Cas9 knockout screening in Aspergillus nidulans, we identified the N-terminal histidine methyltransferase (NHMT) encoded by the gene AN4663. Targeted proteomics confirmed that NHMT was solely responsible for His1 methylation of LPMOs. NHMT is predicted to encode a unique seven-transmembrane segment anchoring a soluble methyltransferase domain. Co-localization studies showed endoplasmic reticulum residence of NHMT and co-expression in the industrial production yeast Komagataella phaffii with LPMOs resulted in His1 methylation of the LPMOs. This demonstrates the biotechnological potential of recombinant production of proteins and peptides harbouring this unique post-translational modification.

2023-07-14 | PXD037734 | Pride